Efficacy and safety of daclizumab induction for primary kidney transplant recipients in combination with tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression

By Ciancio G.   Burke G.W.   Suzart K.   Vaidya A.   Roth D.   Kupin W.   Mattiazzi A.   Rosen A.   Esquenazi V.   Miller J.  

Transplantation Proceedings, Vol. 35, Iss. 2, 2003-03 ,pp. : 873-874

Elsevier

Access to resources Recommend Favorite

Posttransplant diabetes mellitus in kidney transplant recipients under tacrolimus immunosuppression

By Khoury N.   Kriaa F.   Hiesse C.   Von Ey F.   Durbach A.   Ammor M.   Hafi A.   Djeffal R.   Boubenider S.   Droupy S.   Hammoudi Y.   Eschwege P.   Benot G.   Charpentier B.  

Transplantation Proceedings, Vol. 32, Iss. 8, 2000-12 ,pp. : 2763-2764

Elsevier

Access to resources Recommend Favorite

Primary tacrolimus immunosuppression in kidney recipients considered ''higher immunologic risk''

By Braun F.   Lorf T.   Schutz E.   Canelo R.   Hanack U.   Dopkens K.   Sattler B.   Grupp C.   Ringe B.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 2535-2535

Elsevier

Access to resources Recommend Favorite

Primary tacrolimus immunosuppression in kidney recipients considered ''higher immunological risk''

By Braun F.   Lorf T.   Schutz E.   Canelo R.   Hanack U.   Dopkens K.   Sattler B.   Grupp C.   Ringe B.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1688-1688

Elsevier

Access to resources Recommend Favorite

Conversion to tacrolimus in case-problem kidney transplant recipients under cyclosporine-based immunosuppression

By Martins L.   Henriques A.C.   Dias L.   Sarmento A.M.   Pereira M.C.   Guimaraes S.  

Transplantation Proceedings, Vol. 32, Iss. 8, 2000-12 ,pp. : 2636-2638

Elsevier

Access to resources Recommend Favorite